Exact Sciences
EXAS
#1768
Rank
S$12.65 B
Marketcap
$68.39
Share price
-3.29%
Change (1 day)
-15.91%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of September 2024 : S$4.26 Billion

According to Exact Sciences's latest financial reports the company has S$4.26 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$4.15 B1.82%
2022-12-31$S$4.07 B-10.92%
2021-12-31$S$4.57 B54.85%
2020-12-31$S$2.95 B-4.12%
2019-12-31$S$3.08 B231.59%
2018-12-31$S$0.93 B33.65%
2017-12-31$S$0.69 B43.44%
2016-12-31$S$0.48 B4.96%
2015-12-31$S$0.46 B21.08%
2014-12-31$S$0.38 B122.73%
2013-12-31$S$0.17 B42.19%
2012-12-31$S$0.12 B11.51%
2011-12-31$S$0.10 B5.25%
2010-12-31$S$0.10 B1100.8%
2009-12-31$S$8.55 M-345.88%
2008-12-31$-S$3.48 Million-138.45%
2007-12-31$S$9.04 M-60.55%
2006-12-31$S$22.93 M-44.05%
2005-12-31$S$40.99 M-33.84%
2004-12-31$S$61.96 M198.26%
2003-12-31$S$20.77 M-68.78%
2002-12-31$S$66.54 M-39.04%
2001-12-31$S$0.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$0.98 B-76.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.56 B-63.37%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.38 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$103.95 B 2,337.36%๐Ÿ‡ซ๐Ÿ‡ท France